[Prevention of retrolental fibroplasia by administration of water soluble vitamin E (preliminary report)].
D001766:Blindness / Q000517:prevention & control; D002986:Clinical Trials as Topic; D006801:Humans; D007231:Infant, Newborn; D012178:Retinopathy of Prematurity / Q000517:prevention & control*; D012995:Solubility; D014810:Vitamin E / Q000008:administration & dosage / Q000627:therapeutic use*
D014810:Vitamin E
A retrolentalis fibroplasia megelözése vízoldékony E-vitamin adásával (Elözetes közlemény).